Yifeng
Yifeng Pharmacy Chain Co., Ltd. engages in pharmaceutical retail business in China.
Yifeng, founded in June, 2008 and headquartered in Changde, is a national large-scale pharmaceutical retail chain enterprise. The founder is Gao Yi. Listed on the SSE on February 17, 2015, the company's major shareholders are Ningbo Meishan Bonded Port Zone Jikang Enterprise Management Partnership (LP), Hong Kong Central Clearing Co., Ltd. and Gao Yi. Rivals that have direct and indirect competition with Yifeng include 111 Group, JD health, Glaxo Smith Kline, Pfizer, etc.
China Craft Beer Market Booming: Players in and Massive Growth Ahead
Beer lovers across the country are now beginning to explore new favorites like craft beers, creating new opportunities for domestic as well as foreign companies. In this article, we look at the characteristics, evolution, and future projections of China's craft beer market.
Apr 20, 2023 04:30 PM
Pharmaceutical business concept stocks quickly rose the first pharmaceutical trading limit
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Consumer Discretionary, Real Estate, HealthcareTech for Global, Globalization Footprints of the Established and the New
Rice ball takeout has officially entered the Australian market, and high-quality takeout services have captured overseas food
Robosen completed round B and round B + financing of nearly US $100 million
The new brand Hutou Bureau has signed a strategic cooperation with tmall. In the future, heavy new products will be launched in tmall
TOPS in Shanghai: The New Trends in the Pet Industry's Overseas Expansion
After a two-year hiatus, the largest and most influential pet products expo in China has finally returned to the banks of the Huangpu River.
May 12, 2023 01:33 PM
Happy cake has completed a new round of financing of RMB 100 million, led by Asian business capital and followed by Chunjian capital. The listing plan will be launched in the future
Weixiaofan, a new digital fast food brand, has completed a round of financing of nearly 100 million yuan, with Tiantu's exclusive investment
Jingdong double 11 was fully opened, and 190 million goods were sold in 4 hours
HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D
Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.
Apr 23, 2023 12:20 PM
Yuntianhua: the shareholder completed the reduction of 2% of the shares with the investment of Yuntianhua
"Odor library" completed round B financing and Puig entered the market to accelerate the outbreak of the brand
Pinduoduo generates profit while continuing strong growth
Yifeng: Xiao Zaixiang, the Vice President, Intends to Sell Shares